Categoria: EM=MS

ME = MS

MS Research Australia’s CEO celebrates role of new technologies in transforming the lives of people affected by MS   26th June 2017 Chief Executive of MS Research Australia, Matthew Miles, highlighted the potential of new...

Leia mais

EM = MS

MS Research Highlights of 2016     Professor Alan Thompson highlights some of 2016’s research discoveries in MS Last updated: 24th January 2017   In the latest issue of the Lancet Neurology journal, Professor Alan...

Leia mais

EM = MS

Neonatal vitamin D and the risk of MS   Further evidence shows the role of vitamin D in MS risk, especially during pregnancy Last updated: 17th January 2017   Previous research has shown that vitamin D levels during...

Leia mais

EM = MS

Misdiagnosis of MS   Study identifies that migraine and fibromyalgia are frequently misdiagnosed as MS Last updated: 15th November 2016   MS is complex and can cause many different symptoms. There are a range of tests...

Leia mais

EM = MS

Alemtuzumab vs interferon in relapsing remitting MS Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS Last updated: 14th November 2016   Alemtuzumab is a...

Leia mais

EM = MS

Use of metabolic syndrome drugs in multiple sclerosis Drugs used for metabolic syndrome may reduce MS activity in people with MS and obesity Last updated: 28th September 2016   Metabolic syndrome is the medical term for a...

Leia mais

EM = MS

Bigger brains can protect against physical disability Research suggests that higher brain growth is linked to lower risk for disability progression in people with MS Last updated: 28th September 2016   Brain cells can...

Leia mais

EM = MS

Predicting long-term disability in MS Australian researchers aim to predict future worsening of disability in people with relapse-onset MS Last updated: 28th September 2016   If a neurologist could tell a person with MS, as...

Leia mais

EM = MS

Mitoxantrone and risk of cancer in MS German study asks whether recipients of mitoxantrone are more likely than the general population to develop cancers Last updated: 28th September 2016   Mitoxantrone is a chemotherapy...

Leia mais

EM = MS

A new gene target for progressive MS A mutation in a gene called NR1H3 could increase the risk of progressive MS Last updated: 28th September 2016   A complex, and yet unknown, interaction between nature and nurture...

Leia mais

EM = MS

Effects of an immune system gene on MS subtypes and MRI HLA alleles are found to be associated with brain atrophy and a younger age of MS onset in women Last updated: 28th September 2016   A specific area on a human...

Leia mais

EM = MS

Stem cell treatment halts MS progression Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study Last updated: 28th September 2016   The immune system is essential for life and...

Leia mais